Advertisement
Canada markets close in 24 minutes
  • S&P/TSX

    22,174.95
    -171.81 (-0.77%)
     
  • S&P 500

    5,266.29
    -40.72 (-0.77%)
     
  • DOW

    39,077.84
    -593.20 (-1.50%)
     
  • CAD/USD

    0.7279
    -0.0026 (-0.36%)
     
  • CRUDE OIL

    76.78
    -0.79 (-1.02%)
     
  • Bitcoin CAD

    92,738.03
    -2,967.94 (-3.10%)
     
  • CMC Crypto 200

    1,459.51
    -43.15 (-2.87%)
     
  • GOLD FUTURES

    2,335.50
    -57.40 (-2.40%)
     
  • RUSSELL 2000

    2,043.56
    -38.15 (-1.83%)
     
  • 10-Yr Bond

    4.4750
    +0.0410 (+0.92%)
     
  • NASDAQ

    16,723.07
    -78.47 (-0.47%)
     
  • VOLATILITY

    13.12
    +0.83 (+6.76%)
     
  • FTSE

    8,339.23
    -31.10 (-0.37%)
     
  • NIKKEI 225

    39,103.22
    +486.12 (+1.26%)
     
  • CAD/EUR

    0.6732
    -0.0013 (-0.19%)
     

Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule

Maravai LifeSciences Holdings LLC
Maravai LifeSciences Holdings LLC

SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the months of May and June.

On May 15, 2024, at 3:15 p.m. EST, Trey Martin, Chief Executive Officer and Kevin Herde, Chief Financial Officer, will participate in a fireside chat at the RBC Healthcare Conference in New York City, NY.

On June 11, 2024, at 1:20 p.m. EST, Trey Martin, Chief Executive Officer and Kevin Herde, Chief Financial Officer, will participate in a fireside chat at the Goldman Sachs Healthcare Conference in Miami Beach, FL.

ADVERTISEMENT

A live webcast of each presentation will be available to all interested parties on the Maravai LifeSciences Investor Relations website, under News & Events, Upcoming events. An archived version of the webcast will also be available on the Maravai website after the event is completed.

About Maravai

Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world’s leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapies companies.

For more information about Maravai LifeSciences, visit www.maravai.com.

CONTACT: Contact Information: Investor Contact: Deb Hart Maravai LifeSciences +1 858-988-5917 ir@maravai.com